Nightingale is an indica-heavy variety, and results from crossbreeding CD-1 and Oldberry. This strain houses tremendous amounts of CBD, a cannabinoid becoming increasingly well-known for its therapeutic potential.
Nightingale offers about 14% THC and 19% CBD. Due to the huge levels of medicinal cannabinoids, the strain is reported to potentially assist with conditions such as chronic pain, muscle spasms, nausea, vomiting, fibromyalgia, multiple sclerosis, lupus, and insomnia. The indica nature of the strain makes its physical attributes particularly effective in the evening.